D Walmrath, A Gunther, HA Ghofrani, R Schermuly, T Schneider, F Grimminger and W Seeger
Department of Medicine, Justus-Liebig University, Giessen, Germany.

The present study was performed on 10 patients with severe adult respiratory distress syndrome (ARDS), all suffering from sepsis (mean lung injury score [LIS] (1): 3.25 +/- 0.1; duration of mechanical ventilation upon study entry: 3.1 +/- 0.6 d). Ex vivo analysis of the alveolar surfactant system, obtained by bronchoalveolar lavage (BAL), showed severe impairment of surfactant function. Three hundred milligrams of natural surfactant/kg body weight (Alveofact) was delivered bronchoscopically in separate doses to each segment of both lungs. This caused an immediate increase in PaO2/FlO2 from 85 +/- 7 mm Hg to 200 +/- 20 mm Hg (p < 0.001), mainly due to a decrease in shunt flow (42 +/- 4 to 20 +/- 2% [p < 0.001]). Reanalysis of the alveolar surfactant showed that its function was significantly improved. In five patients the increase in arterial oxygenation was partially lost within the next few hours, and a second dose of 200 mg/kg surfactant was applied 18 to 24 h later, again increasing PaO2/FlO2 values. Eight patients survived the subsequent 14-d observation period with progressive improvement of gas exchange, and five patients were definitely weaned from the respirator. All fatalities were due to non- respiratory causes. We conclude that the bronchoscopic application of a high dose of surfactant aimed at overcoming inhibitory factors in the alveolar space of these patients, may offer a feasible and safe approach to improving gas exchange in severe ARDS.

This article has been cited by other articles:

				A. Gunther, B. Enke, P. Markart, P. Hammerl, H. Morr, J. Behr, G. Stahler, W. Seeger, F. Grimminger, I. Leconte, et al. Safety and tolerability of bosentan in idiopathic pulmonary fibrosis: an open label study Eur. Respir. J., April 1, 2007; 29(4): 713 - 719. [Abstract] [Full Text] [PDF]

				M. Ghodrat Lung surfactants. Am. J. Health Syst. Pharm., August 15, 2006; 63(16): 1504 - 1521. [Abstract] [Full Text] [PDF]

				M. Cepkova and M. A. Matthay Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome. J Intensive Care Med, May 1, 2006; 21(3): 119 - 143. [Abstract] [PDF]

				B. S. Burleson and E. D. Maki Acute Respiratory Distress Syndrome Journal of Pharmacy Practice, April 1, 2005; 18(2): 118 - 131. [Abstract] [PDF]

				R. G. Spragg, J. F. Lewis, H.-D. Walmrath, J. Johannigman, G. Bellingan, P.-F. Laterre, M. C. Witte, G. A. Richards, G. Rippin, F. Rathgeb, et al. Effect of Recombinant Surfactant Protein C-Based Surfactant on the Acute Respiratory Distress Syndrome N. Engl. J. Med., August 26, 2004; 351(9): 884 - 892. [Abstract] [Full Text] [PDF]

				A. Gunther, M. Balser, R. Schmidt, P. Markart, A. Olk, J. Borgermann, F. H. Splittgerber, W. Seeger, and I. Friedrich Surfactant abnormalities after single lung transplantation in dogs: Impact of bronchoscopic surfactant administration J. Thorac. Cardiovasc. Surg., February 1, 2004; 127(2): 344 - 354. [Abstract] [Full Text] [PDF]

				Y.-Z. Wu, S. Medjane, S. Chabot, F. S. Kubrusly, I. Raw, M. Chignard, and L. Touqui Surfactant Protein-A and Phosphatidylglycerol Suppress Type IIA Phospholipase A2 Synthesis via Nuclear Factor-{kappa}B Am. J. Respir. Crit. Care Med., September 15, 2003; 168(6): 692 - 699. [Abstract] [Full Text] [PDF]

				E. Koletsis, A. Chatzimichalis, V. Fotopoulos, K. Kokkinis, E. Papadimitriou, D. Tiniakos, E. Marinos, I. Bellenis, and D. Dougenis Donor Lung Pretreatment with Surfactant in Experimental Transplantation Preserves Graft Hemodynamics and Alveolar Morphology Experimental Biology and Medicine, May 1, 2003; 228(5): 540 - 545. [Abstract] [Full Text] [PDF]

				R. V. Diemel, M. M. E. Snel, A. J. Waring, F. J. Walther, L. M. G. van Golde, G. Putz, H. P. Haagsman, and J. J. Batenburg Multilayer Formation upon Compression of Surfactant Monolayers Depends on Protein Concentration as Well as Lipid Composition. AN ATOMIC FORCE MICROSCOPY STUDY J. Biol. Chem., June 7, 2002; 277(24): 21179 - 21188. [Abstract] [Full Text] [PDF]

				A. Gunther, R. Schmidt, J. Harodt, T. Schmehl, D. Walmrath, C. Ruppert, F. Grimminger, and W. Seeger Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on biophysical and biochemical surfactant properties Eur. Respir. J., May 1, 2002; 19(5): 797 - 804. [Abstract] [Full Text] [PDF]

				D. Walmrath, F. Grimminger, D. Pappert, C. Knothe, U. Obertacke, A. Benzing, A. Gunther, T. Schmehl, H. Leuchte, and W. Seeger Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on gas exchange and haemodynamics Eur. Respir. J., May 1, 2002; 19(5): 805 - 810. [Abstract] [Full Text] [PDF]

				F.K. Tegtmeyer, J. Moller, and P. Zabel Inhibition of granulocyte activation by surfactant in a 2-yr-old female with meningococcus-induced ARDS Eur. Respir. J., April 1, 2002; 19(4): 776 - 779. [Abstract] [Full Text] [PDF]

				S. Wolf, H. Lohbrunner, T. Busch, A. Sterner-Kock, M. Deja, A. Sarrafzadeh, U. Neumann, and U. Kaisers Small dose of exogenous surfactant combined with partial liquid ventilation in experimental acute lung injury: effects on gas exchange, haemodynamics, lung mechanics, and lung pathology Br. J. Anaesth., October 1, 2001; 87(4): 593 - 601. [Abstract] [Full Text] [PDF]

				K. Tashiro, K. Yamada, T. Konzaki, K. Yamamoto, S. Ohmura, T. Kobayashi, and Y. Suzuki Aerosolized surfactant therapy for endotoxin-induced experimental acute respiratory distress syndrome in rats Br. J. Anaesth., August 1, 2001; 87(2): 266 - 271. [Abstract] [Full Text] [PDF]

				K. J. Cassidy, J. L. Bull, M. R. Glucksberg, C. A. Dawson, S. T. Haworth, R. Hirschl, N. Gavriely, and J. B. Grotberg A rat lung model of instilled liquid transport in the pulmonary airways J Appl Physiol, May 1, 2001; 90(5): 1955 - 1967. [Abstract] [Full Text] [PDF]

				R. T. Schermuly, A. Gunther, M. Ermert, L. Ermert, H. A. Ghofrani, N. Weissmann, F. Grimminger, W. Seeger, and D. Walmrath Conebulization of surfactant and urokinase restores gas exchange in perfused lungs with alveolar fibrin formation Am J Physiol Lung Cell Mol Physiol, April 1, 2001; 280(4): L792 - L800. [Abstract] [Full Text] [PDF]

				E. Herting, O. Gefeller, M. Land, L. van Sonderen, K. Harms, B. Robertson, and Members of the Collaborative European Multicenter Surfactant Treatment of Neonates With Respiratory Failure and Group B Streptococcal Infection Pediatrics, November 1, 2000; 106(5): 957 - 964. [Abstract] [Full Text]

				P. Rauprich, O. Moller, G. Walter, E. Herting, and B. Robertson Influence of Modified Natural or Synthetic Surfactant Preparations on Growth of Bacteria Causing Infections in the Neonatal Period Clin. Vaccine Immunol., September 1, 2000; 7(5): 817 - 822. [Abstract] [Full Text] [PDF]

				R. Mora, S. Arold, Y. Marzan, B. Suki, and E. P. Ingenito Determinants of surfactant function in acute lung injury and early recovery Am J Physiol Lung Cell Mol Physiol, August 1, 2000; 279(2): L342 - L349. [Abstract] [Full Text] [PDF]

				R. G. Spragg, R. M. Smith, K. Harris, J. Lewis, D. Hafner, and P. Germann Effect of recombinant SP-C surfactant in a porcine lavage model of acute lung injury J Appl Physiol, February 1, 2000; 88(2): 674 - 681. [Abstract] [Full Text] [PDF]

				R. G. Spragg and J. Li Effect of Phosphocholine Cytidylyltransferase Overexpression on Phosphatidylcholine Synthesis in Alveolar Type II Cells and Related Cell Lines Am. J. Respir. Cell Mol. Biol., January 1, 2000; 22(1): 116 - 124. [Abstract] [Full Text]

				R. T. SCHERMULY, A. GÜNTHER, N. WEISSMANN, H. A. GHOFRANI, W. SEEGER, F. GRIMMINGER, and D. WALMRATH Differential Impact of Ultrasonically Nebulized Versus Tracheal-instilled Surfactant on Ventilation-Perfusion (VA/Q) Mismatch in a Model of Acute Lung Injury Am. J. Respir. Crit. Care Med., January 1, 2000; 161(1): 152 - 159. [Abstract] [Full Text]

				T. E. WISWELL, R. M. SMITH, L. B. KATZ, L. MASTROIANNI, D. Y. WONG, D. WILLMS, S. HEARD, M. WILSON, R. D. HITE, A. ANZUETO, et al. Bronchopulmonary Segmental Lavage with Surfaxin (KL4-Surfactant) for Acute Respiratory Distress Syndrome Am. J. Respir. Crit. Care Med., October 1, 1999; 160(4): 1188 - 1195. [Abstract] [Full Text]

				E. HERTING, X. GAN, P. RAUPRICH, C. JARSTRAND, and B. ROBERTSON Combined Treatment with Surfactant and Specific Immunoglobulin Reduces Bacterial Proliferation in Experimental Neonatal Group B Streptococcal Pneumonia Am. J. Respir. Crit. Care Med., June 1, 1999; 159(6): 1862 - 1867. [Abstract] [Full Text]

				J. LEWIS, L. MCCAIG, D. HÄFNER, R. SPRAGG, R. VELDHUIZEN, and C. KERR Dosing and Delivery of a Recombinant Surfactant in Lung-injured Adult Sheep Am. J. Respir. Crit. Care Med., March 1, 1999; 159(3): 741 - 747. [Abstract] [Full Text]

				V. BALARAMAN, J. MEISTER, T. L. KU, S. L. SOOD, E. TAM, J. KILLEEN, C. F. T. UYEHARA, E. EGAN, and D. EASA Lavage Administration of Dilute Surfactants after Acute Lung Injury in Neonatal Piglets Am. J. Respir. Crit. Care Med., July 1, 1998; 158(1): 12 - 17. [Abstract] [Full Text] [PDF]

				D. HAFNER, P.-G. GERMANN, and D. HAUSCHKE Effects of rSP-C Surfactant on Oxygenation and Histology in a Rat-Lung-Lavage Model of Acute Lung Injury Am. J. Respir. Crit. Care Med., July 1, 1998; 158(1): 270 - 278. [Abstract] [Full Text] [PDF]

				X.-c. Jiang, J. D'Armiento, R. K. Mallampalli, J. Mar, S.-F. Yan, and M. Lin Expression of Plasma Phospholipid Transfer Protein mRNA in Normal and Emphysematous Lungs and Regulation by Hypoxia J. Biol. Chem., June 19, 1998; 273(25): 15714 - 15718. [Abstract] [Full Text] [PDF]

				R. SCHERMULY, T. SCHMEHL, A. GÜNTHER, F. GRIMMINGER, W. SEEGER, and D. WALMRATH Ultrasonic Nebulization for Efficient Delivery of Surfactant in a Model of Acute Lung Injury . Impact on Gas Exchange Am. J. Respir. Crit. Care Med., July 1, 1997; 156(2): 445 - 453. [Abstract] [Full Text]

				A. J. DAVIS, A. H. JOBE, D. HÄFNER, and M. IKEGAMI Lung Function in Premature Lambs and Rabbits Treated with a Recombinant SP-C Surfactant Am. J. Respir. Crit. Care Med., February 1, 1997; 157(2): 553 - 559. [Abstract] [Full Text]

				E. Herting, B. Sun, C. Jarstrand, T. Curstedt, and B. Robertson Surfactant improves lung function and mitigates bacterial growth in immature ventilated rabbits with experimentally induced neonatal group B streptococcal pneumonia Arch. Dis. Child. Fetal Neonatal Ed., January 1, 1997; 76(1): 3F - 8. [Abstract] [Full Text]